Compare · KRMD vs MDLN
KRMD vs MDLN
Side-by-side comparison of KORU Medical Systems Inc. (KRMD) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both KRMD and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $57.01B, about 308.8x KRMD ($184.7M).
- Over the past year, KRMD is up 44.4% and MDLN is up 6.5% - KRMD leads by 37.9 points.
- MDLN has been more active in the news (5 items in the past 4 weeks vs 3 for KRMD).
- MDLN has more recent analyst coverage (25 ratings vs 6 for KRMD).
- Company
- KORU Medical Systems Inc.
- Medline Inc.
- Price
- $3.97-2.22%
- $43.39-1.92%
- Market cap
- $184.7M
- $57.01B
- 1M return
- -6.37%
- +1.82%
- 1Y return
- +44.36%
- +6.48%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 3
- 5
- Recent ratings
- 6
- 25
KORU Medical Systems Inc.
Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
Latest KRMD
- KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026
- SEC Form DEF 14A filed by KORU Medical Systems Inc.
- Amendment: SEC Form 4 filed by Manko Joseph M. Jr.
- KORU Medical Systems Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form 4 filed by Wholihan Edward
- SEC Form 4 filed by Cascella Robert
- SEC Form 4 filed by French Donna
- SEC Form 4 filed by Matin Shahriar
- SEC Form 4 filed by Fletcher R John
- SEC Form 4 filed by Manko Joseph M. Jr.
Latest MDLN
- SEC Form DEFA14A filed by Medline Inc.
- SEC Form DEF 14A filed by Medline Inc.
- Medline announces first-in-healthcare AI robotics partnership with Symbotic
- Medline to report first quarter 2026 results on May 6, 2026
- Medline launches custom product fulfillment technology called Pick Pack Pro™
- Medline recognizes manufacturing facilities with Golden Cone Safety Award
- Medline receives HIRC Member Choice Awards for supply chain achievement and renews Transparency Badge distinction
- Director Healy Patrick J acquired 577,510 shares, increasing direct ownership by 73% to 1,208,159 units (SEC Form 4)
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,058,524,148 worth of shares (26,131,237 units at $40.51) and disposed of 2,088,086 shares (SEC Form 4)
- Large owner Cp Circle Ml Holdco Gp, Llc sold $1,070,339,440 worth of shares (26,105,840 units at $41.00) and disposed of 2,113,483 shares (SEC Form 4)